预防性穿皮冠状动脉干预与脆弱斑块的最佳医疗治疗:一个元分析
Yating Chen1, Xiaochen Liu1, Yuyao Qiu1
1Center for Coronary Artery Disease, Division of Cardiology, Beijing Anzhen Hospital, Capital Medical University, No. 2, Anzhen Road, Chao Yang District, Beijing, 100029, China.
BMC cardiovascular disorders
|July 19, 2025
概括
预防性穿皮冠状动脉干预 (PCI) 加上最佳医学治疗 (OMT) 在易受损伤的斑块患者中没有增加主要心脏不良事件 (MACE). 然而,与单独OMT相比,PCI加OMT减少了心血管再循环和心痛住院.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 易受伤害的斑块研究
背景情况:
- 预防性穿皮冠状动脉干预 (PCI) 对非流量限制脆弱冠状动脉斑块的作用尚未得到充分证实.
- 对于这种干预措施的安全性和有效性存在不确定性.
研究的目的:
- 评估预防性PCI与最佳医疗治疗 (OMT) 相结合的影响,而不是单独使用OMT.
- 评估非流量限制敏感斑块患者的临床结果.
主要方法:
- 进行了对4项随机临床试验的元分析,涉及1843名参与者.
- 通过对PubMed,Embase,Web of Science和Cochrane数据库的搜索确定了研究,截至2024年10月.
- 主要结局是主要的不良心脏事件 (MACE);次要结局包括再血管和痛相关的住院治疗.
主要成果:
- 在PCI加OMT组和OMT单独组之间没有观察到MACE的显著差异 (RR=0.38;P=0.16).
- 个别的MACE组件,包括全因死亡和心肌梗塞,也显示没有统计差异.
- 在PCI加OMT组中,临床驱动的复血管化 (RR=0.11;P<0.001) 和因不稳定或渐进性胸痛住院 (RR=0.16;P=0.004) 的显著减少.
结论:
- 在患有非流量限制脆弱斑块的患者中,预防性PCI加OMT导致与单独OMT相比的MACE率相似.
- PCI加上OMT在减少因心痛而需要重血管和住院治疗方面显示出显著的益处.
更多相关视频
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
4.0K
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
5.4K
相关概念视频
01:27Coronary Artery Disease V: Interprofessional Care
34
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
34
01:27Peripheral Artery Disease III: Interprofessional Care
30
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
30
01:26Atherosclerosis III: Management
36
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
36
01:28Acute Coronary Syndrome IV: Interprofessional Care
30
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
30
01:26Angina IV: Management
25
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
25
01:26Coronary Artery Disease IV: Preventive Measures
36
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
36